Femasys Inc. (FEMY)
USD 1.08
(-5.26%)
USD 1.08
(-5.26%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.2 Million USD | 15.59% |
| 2022 | 12.36 Million USD | 35.19% |
| 2021 | 9.14 Million USD | 19.33% |
| 2020 | 7.66 Million USD | -37.9% |
| 2019 | 12.34 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 4.41 Million USD | 35.34% |
| 2024 Q1 | 3.42 Million USD | -21.21% |
| 2023 Q2 | 3.14 Million USD | -2.62% |
| 2023 FY | 14.29 Million USD | 15.59% |
| 2023 Q4 | 4.34 Million USD | 2.42% |
| 2023 Q3 | 4.23 Million USD | 34.76% |
| 2023 Q1 | 3.23 Million USD | 2.58% |
| 2022 Q2 | 2.86 Million USD | -7.16% |
| 2022 Q1 | 3.08 Million USD | 20.95% |
| 2022 Q4 | 3.14 Million USD | -3.79% |
| 2022 FY | 12.36 Million USD | 35.19% |
| 2022 Q3 | 3.27 Million USD | 14.42% |
| 2021 FY | 9.14 Million USD | 19.33% |
| 2021 Q2 | 2.11 Million USD | 2.72% |
| 2021 Q4 | 2.54 Million USD | 5.47% |
| 2021 Q3 | 2.41 Million USD | 13.97% |
| 2021 Q1 | 2.06 Million USD | 11.06% |
| 2020 FY | 7.66 Million USD | -37.9% |
| 2020 Q1 | 2.4 Million USD | 0.0% |
| 2020 Q4 | 1.85 Million USD | 3.92% |
| 2020 Q3 | 1.78 Million USD | 10.92% |
| 2020 Q2 | 1.61 Million USD | -33.06% |
| 2019 FY | 12.34 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 85.422% |
| AngioDynamics, Inc. | 252.41 Million USD | 93.978% |
| AtriCure, Inc. | 327.05 Million USD | 95.352% |
| Avinger, Inc. | 18.63 Million USD | 18.444% |
| Azenta, Inc. | 336.26 Million USD | 95.48% |
| BioLife Solutions, Inc. | 117.57 Million USD | 87.072% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.167% |
| Daxor Corporation | 1.28 Million USD | -1087.047% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 37.165% |
| GlucoTrack, Inc. | 7.1 Million USD | -113.968% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 74.052% |
| Hologic, Inc. | 1.34 Billion USD | 98.87% |
| ICU Medical, Inc. | 717.04 Million USD | 97.88% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.487% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 41.779% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 83.174% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 12838.158% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 12838.158% |
| Masimo Corporation | 867 Million USD | 98.247% |
| Microbot Medical Inc. | 9.85 Million USD | -54.24% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 17.48% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 96.695% |
| Nephros, Inc. | 9.78 Million USD | -55.359% |
| NovoCure Limited | 613.92 Million USD | 97.524% |
| NEXGEL, Inc. | 4.09 Million USD | -271.101% |
| NEXGEL, Inc. | 4.09 Million USD | -271.101% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 85.133% |
| OraSure Technologies, Inc. | 125.34 Million USD | 87.873% |
| Pro-Dex, Inc. | 7.37 Million USD | -106.022% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 65.116% |
| Predictive Oncology Inc. | 15.22 Million USD | 0.192% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -78.363% |
| QuidelOrtho Corporation | 1.35 Billion USD | 98.878% |
| Repligen Corporation | 261.12 Million USD | 94.179% |
| Sanara MedTech Inc. | 61.12 Million USD | 75.133% |
| STAAR Surgical Company | 224.55 Million USD | 93.231% |
| Sharps Technology, Inc. | 10.12 Million USD | -50.102% |
| Utah Medical Products, Inc. | 13.26 Million USD | -14.624% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.153% |
| Jin Medical International Ltd. | 3.91 Million USD | -288.003% |